Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Former FDA Commissioner Dr. Scott Gottlieb discusses the impact of the AI drug revolution and Moderna’s partnership with OpenAI to expand its employees' access to AI chatbots. https://t.co/ZffErAKC18 https://t.co/9gfSSiZtvs
"If AI can help us deal with that new data more efficiently & make sure that we're setting up experiments in productive ways & learning all that we can from the results, that's great news. But we can't skip the experiments themselves." - Derek Lowe/In The Pipline column in… https://t.co/PE44olgHzi
"the most badly needed improvements in drug discovery are in the exact areas that are most resistant to AI & machine learning techniques. By which I mean target selection & predictive toxicology. Uncountable billions of dollars and years of work have been torched by not (in the… https://t.co/XDfXBCnToY
AI is transforming drug discovery, with companies like Moderna and Xaira Therapeutics leveraging AI techniques. OpenAI's ChatGPT Enterprise is being used to scale GPTs at Moderna. While generative AI shows promise for clinical documentation, challenges remain in the short term. ETH Zurich and Roche collaborate on a new AI algorithm for drug discovery.